Darifenacin

FDA Drug Profile — Darifenacin

Drug Details

Generic Name
Darifenacin
Brand Names
Darifenacin
Application Number
ANDA205209
Sponsor
Torrent Pharmaceuticals Limited
NDC Codes
10
Dosage Forms
TABLET, EXTENDED RELEASE, TABLET, FILM COATED, EXTENDED RELEASE
Routes
ORAL
Active Ingredients
DARIFENACIN HYDROBROMIDE

Indications and Usage

1 INDICATIONS AND USAGE Darifenacin extended-release tablets are muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency. Darifenacin is a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency. ( 1 )